Director, Renal Denervation (RDN) Health Economics, Policy & Reimbursement Director (HEPR)

We anticipate the application window for this opening will close on - 9 Nov 2026

Careers that change lives start here. Medtronic is a global leader in healthcare technology with a Mission to alleviate pain, restore health, and extend life. Our 95,000 employees work across more than 150 countries to put patients first — developing innovative medical technologies that improve the lives of 72+ million patients each year. Your unique talents will help shape the future of healthcare while building a career grounded in purpose, growth, and impact.

A Day in the Life

Interventional Cardiology Therapies (ICT) brings together Medtronic’s Structural Heart, Coronary, and Renal Denervation businesses to support interventional cardiologists and heart teams with a connected, patient-focused approach. We offer a comprehensive, integrated portfolio of products aligned around the needs of the interventional cardiology service line, including innovative solutions that support the diagnosis and treatment of coronary artery disease, the restoration of structural heart functions, and the management of hypertension.

At Medtronic, we bring bold ideas forward with speed and decisiveness to put patients first in everything we do. This position is remote to enhance our competitive edge and expand our cross-functional collaboration efforts. This role will require 40% of travel to enhance collaboration and ensure successful completion of projects.

The Renal Denervation (RDN) Health Economics, Policy, and Reimbursement (HEPR) Director leads the development and execution of strategies to achieve payer access, demonstrate therapy value, and expand patient access to Medtronic RDN therapies in the United States and globally.

This leadership role drives U.S. and global reimbursement strategy development, business development opportunities, clinical & economic evidence planning, and global commercial product launches for RDN. This position must understand, develop, and communicate the clinical and economic evidence needed to secure public and private payer coverage, coding, and sustainable payment. The role develops business- and therapy-specific reimbursement strategies spanning coding, coverage, and payment/funding, and partners with regional & local market access colleagues to establish, maintain, and protect access in target geographies.

This role closely collaborates with HEPR leadership, Corporate HEPR colleagues, and business, regional, and functional leaders to establish and deliver reimbursement priorities and strategies.

The Director will have a team of direct reports and will collaborate with numerous other HEPR and functional teams that support RDN reimbursement objectives. This is a highly visible role that requires an experienced leader adept at executive leadership communications, matrixed organizational design and maneuverability, and global agility.

Role and Responsibilities

• •Leads overall RDN HEPR strategy and initiatives, in alignment with business priorities and budgets. Responsible for connecting reimbursement and market access plans to business value and growth strategies.
• •Develops and executes integrated U.S. and global market access strategies, incorporating reimbursement, health economics, evidence generation, coding, coverage, payment, and payer value proposition considerations.
• •Collaborates closely with the Payer Engagement team to set and communicate priorities and execute comprehensive tactics to expand U.S. payer coverage.
• •Provides strategic leadership on U.S. Medicare reimbursement pathways, including coverage and payment. This includes continued strategic leadership related to the Medicare RDN National Coverage Determination (NCD) and existing add-on payments, including New Technology Add-on Payments (NTAP) and Transitional Pass-Through (TPT).
• •Defines clinical and economic evidence needs and develops strategic studies with the end customer in mind to ensure that the results will favorably impact reimbursement, market access, pricing, and market uptake. Works with the Health Economics and Outcomes Research (HEOR) team to develop evidence that supports coverage, payment, and the RDN value proposition, and that will build the evidence base for RDN for strategic positioning in the marketplace.

Collaborates closely with international HEPR and HEOR colleagues to develop and execute on global market access strategies for priority RDN markets outside the U.S. Collaboratively execute comprehensive market access strategies by integrating reimbursement, health technology assessment, evidence-based medicine review, pricing, and health economic modeling activities for target markets.

• •Represents HEPR in cross-functional leadership and product development processes so global reimbursement and payer evidence needs are considered early and throughout the product lifecycle.
• •Collaborates closely with the U.S. field reimbursement teams to ensure hospital and physician customers are appropriately informed on therapy reimbursement.
• •Collaborate closely with patient access support teams to ensure appropriate, compliant support of patients navigating coverage challenges with RDN.
• •Partners with Clinical, Regulatory, Marketing, R&D, Business Development and Strategy, Sales, Finance, Government Affairs, and other stakeholders to align plans and advance RDN priorities in a matrixed organization.
• •Builds productive relationships with physicians and other external stakeholders; communicates the clinical and economic value of RDN therapies to payers, providers, policymakers, and advocacy organizations.
• •Develops and executes external engagement and advocacy strategies to support appropriate patient access and sustainable reimbursement.
• •Supports commercial launch planning and execution, including physician and customer education on reimbursement and available access pathways.
• •Partners with patient access and prior authorization support services to identify access barriers and improve the reimbursement experience for patients and providers.
• •Monitors U.S. price transparency data and other market and business analytics; translates findings into clear, concise dashboards and actionable recommendations.
• •Evaluates digital health reimbursement policy changes and develops practical strategies as appropriate for RDN.

• •Prioritizes work across a large portfolio, manages budgets and forecasts, and oversees external vendors and related deliverables.
• •Leads and develops direct reports with a clear management style, effective delegation, an inclusive team mindset, and a strong sense of urgency.
• •Communicates complex policy, reimbursement, clinical, and economic topics clearly in writing and verbally, including to senior-level audiences; uses or explores AI tools where they can support effective work.

Must Have: Minimum Requirements

To be considered for this role, please ensure the minimum requirements are evident in your applicant profile.

• •Bachelor’s degree in health policy, health services research, economics, biostatistics, epidemiology, public administration, clinical research or a related discipline.
• •Minimum of 10 years of medical device or pharmaceutical industry health policy or strategic reimbursement experience with 7+ years of managerial experience, or advanced degree with a minimum of 7 years of medical device or pharmaceutical industry health policy or strategic reimbursement experience with 5+ years of managerial experience.

Nice to Have

• •Master’s degree in health policy, business administration, public administration, or a related discipline.
• •Experience with the reimbursement implications of FDA Breakthrough Device Designation (BDD) and other relevant regulatory and policy pathways.
• •Demonstrated U.S. and global reimbursement experience, including experience with Medicare coverage, U.S. payment pathways, U.S. CPT processes, and commercial payer coverage.
• •Experience with clinical and economic evidence development, ph